| Generic name | Mechlorethamine gel |
| Pronunciation | me-klor-ETH-a-meen gel |
| Brand name(s), other common name(s) | ValchlorTM |
| Drug type | Alkylating drug |
| How the drug is given | Topical |
Indications and Usage
Mechlorethamine gel is FDA approved for the treatment of Stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
Side effects needing medical attention
Skin inflammation; itchy skin; bacterial skin infection; skin ulceration or blistering; skin hyperpigmentation
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.